Free Trial

Aerovate Therapeutics (JBIO) Stock Trends and Sentiment

$6.59 -0.35 (-5.04%)
As of 02:42 PM Eastern

MarketBeat Searches Over Time



Recieve Aerovate Therapeutics News and Ratings via Email

Sign-up to receive the latest news and ratings for JBIO and its competitors with MarketBeat's FREE daily newsletter.

JBIO Social Media Mentions

Related Companies and Tools


This page (NASDAQ:JBIO) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners